<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Mineral oil: Pediatric drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Mineral oil: Pediatric drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Mineral oil: Pediatric drug information</div><div class="clear"></div><div id="topicText">(For additional information <a class="drug drug_general" data-topicid="10213" href="/d/html/10213.html" rel="external">see "Mineral oil: Drug information"</a> and <a class="drug drug_patient" data-topicid="11504" href="/d/html/11504.html" rel="external">see "Mineral oil: Patient drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F2605148"><span class="drugH1">Brand Names: US</span>
<ul>
<li>Fleet Oil [OTC];</li>
<li>FT Mineral Oil [OTC];</li>
<li>GoodSense Mineral Oil [OTC]</li></ul></div>
<div class="list_set htclist drugH1Div drugBrandNames" id="F1048662"><span class="drugH1">Therapeutic Category</span>
<ul>
<li>
<span class="list-set-name">Laxative, Lubricant</span></li></ul></div>
<div class="block dop drugH1Div" id="F2605173"><span class="drugH1">Dosing: Pediatric</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="387e55f0-7a7e-4f50-ab02-5492aebb64f2">Constipation, occasional</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Constipation, occasional: </b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note: </b>Other oral agents (eg, polyethylene glycol 3350) are preferred for pharmacologic constipation therapy. Mineral oil may be used as additional or second-line therapy (NASPGHAN [Tabbers 2014]). Due to risk of lipoid pneumonia, do not use oral mineral oil in patients at risk for aspiration, including infants and patients with neurological impairment, or in patients with significant gastroesophageal reflux, nausea, or vomiting (Colombo 2020; Kurlandsky 1992; Sharif 2001; Spickard 1994; Weinstein 2001).</p>
<p style="text-indent:-2em;margin-left:4em;">Oral: OTC labeling:</p>
<p style="text-indent:-2em;margin-left:6em;">
<i>Plain (nonemulsified) liquid:</i></p>
<p style="text-indent:-2em;margin-left:8em;">Children 6 to &lt;12 years: Oral: 5 to 15 mL/day in a single daily dose at bedtime or in divided doses; maximum daily dose: 15 mL/<b>day.</b></p>
<p style="text-indent:-2em;margin-left:8em;">Children ≥12 years and Adolescents: Oral: 15 to 45 mL/day in a single daily dose at bedtime or in divided doses; maximum daily dose: 45 mL/<b>day.</b></p>
<p style="text-indent:-2em;margin-left:6em;">
<i>Suspension (emulsion) (Kondremul):</i></p>
<p style="text-indent:-2em;margin-left:8em;">Children 6 to &lt;12 years: Oral: 10 to 30 mL/day in a single daily dose or in up to 3 divided doses.</p>
<p style="text-indent:-2em;margin-left:8em;">Children ≥12 years and Adolescents: Oral: 30 to 90 mL/day in a single daily dose or in up to 3 divided doses.</p>
<p style="text-indent:-2em;margin-left:4em;">Rectal: OTC labeling: <b>Note:</b> 118 mL mineral oil is delivered per 133 mL bottle.</p>
<p style="text-indent:-2em;margin-left:6em;">Children 2 to &lt;12 years: Rectal: 59 mL (½ bottle) as a single dose.</p>
<p style="text-indent:-2em;margin-left:6em;">Children ≥12 years and Adolescents: Rectal: 118 mL (full bottle) as a single dose.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="1da5f961-821f-41a1-ab8b-3649d0b0eb72">Constipation, chronic</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Constipation, chronic:</b> Limited data available:</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note:</b> Other oral agents (eg, polyethylene glycol 3350) are preferred for pharmacologic constipation therapy. Mineral oil may be used as additional or second-line therapy (NASPGHAN [Tabbers 2014]). Due to risk of lipoid pneumonia, do not use oral mineral oil in patients at risk for aspiration, including infants, patients with neurological impairment, or in patients with significant gastroesophageal reflux, nausea, or vomiting (Colombo 2020; Kurlandsky 1992; Sharif 2001; Spickard 1994; Weinstein 2001).</p>
<p style="text-indent:-2em;margin-left:4em;">Oral:</p>
<p style="text-indent:-2em;margin-left:6em;">Children and Adolescents: Oral: 1 to 2 mL/kg/day once daily or in divided doses; higher doses of 3 mL/kg/day may be necessary in some patients. Usual maximum daily dose is 45 mL/<b>day</b>; however, some patients may require up to 90 mL/<b>day</b> (NASPGHAN [Tabbers 2014]; manufacturer's labeling).</p>
<p style="text-indent:-2em;margin-left:4em;">Rectal:</p>
<p style="text-indent:-2em;margin-left:6em;">Children 2 to &lt;12 years: Rectal: 30 to 60 mL once daily (NASPGHAN [Tabbers 2014]).</p>
<p style="text-indent:-2em;margin-left:6em;">Children ≥12 years and Adolescents: Rectal: 60 to 150 mL once daily (NASPGHAN [Tabbers 2014]).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="2633c46a-7e2a-45d5-8aa4-184818b49182">Fecal impaction</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Fecal impaction:</b> OTC labeling:</p>
<p style="text-indent:-2em;margin-left:4em;">
<b> Note: </b>Other oral agents (eg, polyethylene glycol 3350) are preferred for pharmacologic constipation therapy. Mineral oil may be used as additional or second-line therapy (NASPGHAN [Tabbers 2014]). 118 mL mineral oil is delivered per 133 mL bottle.</p>
<p style="text-indent:-2em;margin-left:4em;">Children 2 to &lt;12 years: Rectal: 59 mL (½ bottle) as a single dose.</p>
<p style="text-indent:-2em;margin-left:4em;">Children ≥12 years and Adolescents: Rectal: 118 mL (full bottle) as a single dose.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="376bc3ca-88c9-4352-ac74-757643d80b69">Removal of residues following barium administration</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Removal of residues following barium administration: </b>OTC labeling: <b>Note:</b> 118 mL mineral oil is delivered per 133 mL bottle.</p>
<p style="text-indent:-2em;margin-left:4em;">Children 2 to &lt;12 years: Rectal: 59 mL (½ bottle) as a single dose.</p>
<p style="text-indent:-2em;margin-left:4em;">Children ≥12 years and Adolescents: Rectal: 118 mL (full bottle) as a single dose.</p></div>
</div>
</div>
<div class="block doa drugH1Div" id="F2605174"><span class="drugH1">Dosing: Adult</span><p>(For additional information <a class="drug drug_general" data-topicid="10213" href="/d/html/10213.html" rel="external">see "Mineral oil: Drug information"</a>)</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="5cf5683d-351d-423d-a054-afa1e6798e5c">Constipation</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Constipation:</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Oral:</b></p>
<p style="text-indent:-2em;margin-left:6em;">Plain (nonemulsified) liquid: 15 to 45 mL in 24 hours (maximum: 45 mL in 24 hours). May be taken as a single dose (at bedtime) or in divided doses.</p>
<p style="text-indent:-2em;margin-left:6em;">Suspension (emulsion) (Kondremul): 30 to 90 mL daily (maximum: 90 mL daily). May be taken as a single dose or in up to 3 equal divided doses.</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Rectal</b> (Fleet Mineral Oil): 118 mL (full bottle) as a single dose; may repeat no more frequently than once every 24 hours.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="1a430762-e405-4275-ac12-fecaed3b0824">Fecal impaction or following barium studies</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Fecal impaction or following barium studies:</b>
<b>Rectal</b> (Fleet Mineral Oil): 118 mL (full bottle) as a single dose.</p></div>
</div>
</div>
<div class="block dora drugH1Div" id="F53075997"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block doha drugH1Div" id="F53075998"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block adr drugH1Div" id="F2605161"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified. Frequency not defined.</p>
<p style="text-indent:-2em;margin-left:2em;">Gastrointestinal: Abdominal cramps, diarrhea, nausea, oily rectal leakage (large doses; may cause anal irritation, hemorrhoids, perianal discomfort, pruritus ani, soiling of clothes), vomiting</p></div>
<div class="block coi drugH1Div" id="F2605156"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;display:inline">Oral: Children &lt;6 years, pregnancy, bedridden patients, elderly, use longer than 1 week, or difficulty swallowing.</p></div>
<div class="block war drugH1Div" id="F2605157"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Concerns related to adverse effects:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Aspiration: Lipid pneumonitis results from aspiration of mineral oil; risk is increased in patients in prolonged supine position or conditions which interfere with swallowing or epiglottal function (eg, stroke, Parkinson's disease, Alzheimer's disease, esophageal dysmotility).</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Other warnings/precautions:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• OTC labeling: Health care provider should be contacted in case of sudden changes in bowel habits that last over 2 weeks; if abdominal pain, nausea, or vomiting are present prior to use; rectal bleeding occurs following use; or if no bowel movement within 15 minutes of using rectal enema. Do not use for &gt;1 week, unless otherwise directed by health care provider. Do not use orally in children &lt;6 years of age or rectally in children &lt;2 years of age.</p></div>
<div class="block add-pediatric-warn-info drugH1Div" id="F52878690"><span class="drugH1">Warnings: Additional Pediatric Considerations</span>
<p style="text-indent:0em;display:inline">Due to risk of lipoid pneumonia, do not use oral mineral oil in patients at risk for aspiration, including infants and patients with neurological impairment, difficulty swallowing, significant gastroesophageal reflux, nausea, or vomiting (Colombo 2020; Kurlandsky 1992; Paul 2021; Sharif 2001; Spickard 1994; Weinstein 2001).</p></div>
<div class="block foc drugH1Div" id="F2605182"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Enema, Rectal: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Fleet Oil:  (133 mL)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic:  (135 mL [DSC])</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Oil, Oral: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">FT Mineral Oil:  (473 mL) [odorless]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">GoodSense Mineral Oil:  (473 mL) [odorless]</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic:  (30 mL, 472 mL [DSC], 473 mL, 500 mL, 1000 mL, 4000 mL)</p></div>
<div class="block geq drugH1Div" id="F2605150"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">Yes</p></div>
<div class="block adip drugH1Div" id="F53569239"><span class="drugH1">Additional Information</span>
<p style="text-indent:0em;display:inline">Fleet Mineral Oil Enema: 4.5 ounce enema delivers 118 mL.</p></div>
<div class="block admp drugH1Div" id="F52614102"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:-2em;margin-left:2em;">Oral: Mineral oil may be more palatable if refrigerated (NASPGHAN 2006). <b>Note:</b> Due to risk of aspiration, do not administer to patient in supine position.</p>
<p style="text-indent:-2em;margin-left:4em;">Plain (nonemulsified): Administer at least 2 hours before or after other medications. Do not administer with meals.</p>
<p style="text-indent:-2em;margin-left:4em;">Suspension (emulsion) (Kondremul): Shake well before use. May be administered alone or mixed with warm or cold water, milk, or cocoa; do not administer with meals.</p>
<p style="text-indent:-2em;margin-left:2em;">Rectal: Administer with patient lying on left side and knees bent or with patient kneeling and head and chest leaning forward until left side of face is resting comfortably. Remove protective shield and gently insert enema tip into rectum with a slight side-to-side movement with tip pointing toward the navel; have patient bear down. Do not force the enema tip into the rectum as this may cause injury. Squeeze the bottle until correct dose is administered. It is not necessary to empty the bottle completely for a one-bottle dose. Remove enema tip from rectum; patient should maintain position until urge to evacuate is strong (evacuate within 15 minutes).</p></div>
<div class="block adm drugH1Div" id="F2605177"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>Oral:</b> Mineral oil may be more palatable if refrigerated (NASPGHAN 2006). Due to risk of aspiration, do not administer to patient in supine position. Do not take with meals.</p>
<p style="text-indent:-2em;margin-left:4em;">Plain (nonemulsified): Administer at bedtime unless administered in divided doses. Administer at least 2 hours before or after other medications.</p>
<p style="text-indent:-2em;margin-left:4em;">Suspension (emulsion) (Kondremul): Shake well before use. May administer plain or mixed with warm or cold water, milk, or cocoa.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Rectal</b> (Fleet Mineral Oil): Gently insert enema rectally following the instructions on the package labeling.</p></div>
<div class="block sts drugH1Div" id="F23687038"><span class="drugH1">Storage/Stability</span>
<p style="text-indent:-2em;margin-left:2em;">Oral plain (nonemulsified) liquid: Protect from sunlight.</p>
<p style="text-indent:-2em;margin-left:2em;">Oral suspension (emulsion) (Kondremul): Store at 15°C to 25°C (59°F to 77°F).</p>
<p style="text-indent:-2em;margin-left:2em;">Rectal enema: Store at 20°C to 25°C (68°F to 77°F); protect from sunlight.</p></div>
<div class="block usep drugH1Div" id="F53569769"><span class="drugH1">Use</span>
<p style="text-indent:-2em;margin-left:2em;">Oral: Treatment of occasional constipation (OTC product: FDA approved in ≥6 years and adults).</p>
<p style="text-indent:-2em;margin-left:2em;">Rectal: Treatment of occasional constipation; relief of fecal impaction; removal of residues following barium administration (OTC products: Fleet Mineral Oil Enema; All indications: FDA approved in ages ≥2 years and adults).</p></div>
<div class="block mst drugH1Div" id="F9959247"><span class="drugH1">Medication Safety Issues</span>
<div class="collapsible">
<span class="collapsible-title">High alert medication:</span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:4em;">The Institute for Safe Medication Practices (ISMP) includes this medication among its list of drugs that have a heightened risk of causing significant patient harm when used in error.</p></div>
</div>
<div class="collapsible">
<span class="collapsible-title">Older Adult: High-Risk Medication:</span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:4em;">Beers Criteria: Mineral oil (when administered orally) is identified in the Beers Criteria as a potentially inappropriate medication to be avoided in patients 65 years and older (independent of diagnosis or condition) due to its potential for aspiration and adverse events; safer alternatives exist (Beers Criteria [AGS 2023]).</p></div>
</div>
<div class="collapsible">
<span class="collapsible-title">Pediatric patients: High-risk medication:</span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:4em;">KIDs List: Mineral oil, when used in infants &lt;1 year of age and administered orally, is identified on the Key Potentially Inappropriate Drugs in Pediatrics (KIDs) list; use should be avoided due to risk of lipid pneumonitis (strong recommendation; low quality of evidence) (PPA [Meyers 2020]).</p></div>
</div>
</div>
<div class="block cyt drugH1Div" id="F13299716"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F2605165"><span class="drugH1">Drug Interactions</span><br/><br/><div class="clear"></div><p xmlns=""></p><div class="inner" xmlns=""><p style="text-indent:0em;display:inline"><b>Note</b>: Interacting drugs may <b>not be individually listed below</b> if they are part of a group interaction (eg, individual drugs within “CYP3A4 Inducers [Strong]” are NOT listed).  For a complete list of drug interactions by individual drug name and detailed management recommendations, use the Lexicomp drug interactions program by clicking on the “Launch drug interactions program” link above.</p><p xmlns=""></p></div>
<p style="text-indent:-2em;margin-left:2em;">Multivitamins/Fluoride (with ADE): Mineral Oil may decrease the serum concentration of Multivitamins/Fluoride (with ADE).  Management: Avoid concomitant oral administration of mineral oil and multivitamins when possible; consider separating the administration of these agents by several hours to minimize the risk of interaction.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Multivitamins/Minerals (with ADEK, Folate, Iron): Mineral Oil may decrease the serum concentration of Multivitamins/Minerals (with ADEK, Folate, Iron). Specifically, mineral oil may impair the absorption of fat-soluble vitamins.  Management: Avoid concomitant oral administration of mineral oil and multivitamins when possible; consider separating the administration of these agents by several hours to minimize the risk of interaction.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Multivitamins/Minerals (with AE, No Iron): Mineral Oil may decrease the serum concentration of Multivitamins/Minerals (with AE, No Iron).  Management: Avoid concomitant oral administration of mineral oil and multivitamins when possible; consider separating the administration of these agents by several hours to minimize the risk of interaction.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Vitamin D Analogs: Mineral Oil may decrease the serum concentration of Vitamin D Analogs. More specifically, mineral oil may interfere with the absorption of Vitamin D Analogs.  Management: Avoid concomitant, oral administration of mineral oil and vitamin D analogs. Consider separating the administration of these agents by several hours to minimize the risk of interaction. Monitor plasma calcium concentrations.<i> Risk D: Consider therapy modification</i></p></div>
<div class="block dic drugH1Div" id="F2605176"><span class="drugH1">Dietary Considerations</span>
<p style="text-indent:0em;display:inline">Do not administer orally with food or meals because of the risk of aspiration; prolonged administration of mineral oil may decrease absorption of lipid-soluble vitamins A, D, E, and K. Light sterile mineral oils are not for injection.</p></div>
<div class="block pri drugH1Div" id="F14287015"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;">Mineral oil is not recommended for the treatment of constipation in pregnant women. Use may be associated with decreased maternal absorption of fat-soluble vitamins, which may cause adverse maternal and neonatal effects (Body 2016; Gomes 2018).</p></div>
<div class="block mopp drugH1Div" id="F53569738"><span class="drugH1">Monitoring Parameters</span>
<p style="text-indent:0em;display:inline">Stool frequency and consistency, fluid status; serum electrolytes (as clinically appropriate or with prolonged use).</p></div>
<div class="block pha drugH1Div" id="F2605166"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">Eases passage of stool by decreasing water absorption and lubricating the intestine; retards colonic absorption of water</p></div>
<div class="block phk drugH1Div" id="F2605168"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:-2em;margin-left:2em;">Onset of action: Oral: 6 to 8 hours; Rectal: 2 to15 minutes</p>
<p style="text-indent:-2em;margin-left:2em;">Absorption: Minimal following oral or rectal administration</p>
<p style="text-indent:-2em;margin-left:2em;">Distribution: Into intestinal mucosa, liver, spleen, and mesenteric lymph nodes</p>
<p style="text-indent:-2em;margin-left:2em;">Excretion: Feces</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F5549703"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(AR)</span> <span class="country">Argentina</span><span class="countrySeparator">: </span><span class="drugName">Lansoyl | Vaselina</span>;</li>
<li>
<span class="countryCode">(BG)</span> <span class="country">Bulgaria</span><span class="countrySeparator">: </span><span class="drugName">Oleum vaselini</span>;</li>
<li>
<span class="countryCode">(BR)</span> <span class="country">Brazil</span><span class="countrySeparator">: </span><span class="drugName">Dolio | Minerilax | Nujol | Oleo mineral</span>;</li>
<li>
<span class="countryCode">(CH)</span> <span class="country">Switzerland</span><span class="countrySeparator">: </span><span class="drugName">Paragol N</span>;</li>
<li>
<span class="countryCode">(DE)</span> <span class="country">Germany</span><span class="countrySeparator">: </span><span class="drugName">Obstinol m</span>;</li>
<li>
<span class="countryCode">(ES)</span> <span class="country">Spain</span><span class="countrySeparator">: </span><span class="drugName">Emuliquen simple | Ordelax</span>;</li>
<li>
<span class="countryCode">(FR)</span> <span class="country">France</span><span class="countrySeparator">: </span><span class="drugName">Lansoyl</span>;</li>
<li>
<span class="countryCode">(IT)</span> <span class="country">Italy</span><span class="countrySeparator">: </span><span class="drugName">Olio vaselina</span>;</li>
<li>
<span class="countryCode">(NZ)</span> <span class="country">New Zealand</span><span class="countrySeparator">: </span><span class="drugName">Fleet mineral oil</span>;</li>
<li>
<span class="countryCode">(PL)</span> <span class="country">Poland</span><span class="countrySeparator">: </span><span class="drugName">Oilatum</span>;</li>
<li>
<span class="countryCode">(PR)</span> <span class="country">Puerto Rico</span><span class="countrySeparator">: </span><span class="drugName">Mineral oil</span>;</li>
<li>
<span class="countryCode">(RU)</span> <span class="country">Russian Federation</span><span class="countrySeparator">: </span><span class="drugName">Oleum vaselinum</span>;</li>
<li>
<span class="countryCode">(SG)</span> <span class="country">Singapore</span><span class="countrySeparator">: </span><span class="drugName">Fleet enema mineral oil | Laxarol | Liquid paraffin beacons</span>;</li>
<li>
<span class="countryCode">(TN)</span> <span class="country">Tunisia</span><span class="countrySeparator">: </span><span class="drugName">Lubentyl</span>;</li>
<li>
<span class="countryCode">(UA)</span> <span class="country">Ukraine</span><span class="countrySeparator">: </span><span class="drugName">Oleum vaselinum</span>;</li>
<li>
<span class="countryCode">(UY)</span> <span class="country">Uruguay</span><span class="countrySeparator">: </span><span class="drugName">Lansoyl</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-37139824">
<a name="37139824"></a>2023 American Geriatrics Society Beers Criteria Update Expert Panel. American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults. <i>J Am Geriatr Soc</i>. 2023;71(7):2052-2081. doi:10.1111/jgs.18372<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/mineral-oil-pediatric-drug-information/abstract-text/37139824/pubmed" id="37139824" target="_blank">37139824</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27261898">
<a name="27261898"></a>Body C, Christie JA. Gastrointestinal diseases in pregnancy: nausea, vomiting, hyperemesis gravidarum, gastroesophageal reflux disease, constipation, and diarrhea. <i>Gastroenterol Clin North Am</i>. 2016;45(2):267‐283. doi:10.1016/j.gtc.2016.02.005<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/mineral-oil-pediatric-drug-information/abstract-text/27261898/pubmed" id="27261898" target="_blank">27261898</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Colombo JL. Aspiration syndromes. In: Kliegman RM and St. Geme J, eds. <i>Nelson Textbook of Pediatrics</i>. 21st ed. Philadelphia, PA: Saunders Elsevier; 2020: chap 425.</div>
</li>
<li>
<div class="reference">
                  Constipation Guideline Committee of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN). Evaluation and treatment of constipation in infants and children: Recommendations of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition. <i>J Pediatr Gastroenterol Nutr</i>. 2006;43(3):e1-e13.</div>
</li>
<li>
<div class="reference">
                  Fleet (mineral oil enema) [prescribing information]. Lynchburg, VA: C.B. Fleet Company, Inc; 2018</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-29991883">
<a name="29991883"></a>Gomes CF, Sousa M, Lourenço I, Martins D, Torres J. Gastrointestinal diseases during pregnancy: what does the gastroenterologist need to know? <i>Ann Gastroenterol</i>. 2018;31(4):385‐394. doi:10.20524/aog.2018.0264<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/mineral-oil-pediatric-drug-information/abstract-text/29991883/pubmed" id="29991883" target="_blank">29991883</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  GoodSense Mineral Oil [prescribing information]. Peachtree, GA: Geiss, Destin &amp; Dunn Inc; received April 2019.</div>
</li>
<li>
<div class="reference">
                  Humco Mineral Oil Heavy (mineral oil liquid) [prescribing information]. Texarkana, TX: Humco; January 2018.</div>
</li>
<li>
<div class="reference">
                  Kondremul (mineral oil liquid) [prescribing information]. Tarrytown, NY: Insight Pharmaceuticals; December 2021.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-1437335">
<a name="1437335"></a>Kurlandsky LE, Vaandrager V, Davy CL, Stockinger FS. Lipoid pneumonia in association with gastroesophageal reflux. <i>Pediatr Pulmonol</i>. 1992;13(3):184-188. doi:10.1002/ppul.1950130312<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/mineral-oil-pediatric-drug-information/abstract-text/1437335/pubmed" id="1437335" target="_blank">1437335</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-32265601">
<a name="32265601"></a>Meyers RS, Thackray J, Matson KL, et al. <i>K</i>ey Potentially <i>I</i>nappropriate <i>D</i>rugs in Pediatrics: The KIDs List. <i>J Pediatr Pharmacol Ther</i>. 2020;25(3):175-191.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/mineral-oil-pediatric-drug-information/abstract-text/32265601/pubmed" id="32265601" target="_blank">32265601</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  Mineral oil [prescribing information]. Salisburg, NC: DZA Brands, LLC; received March 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-34637057">
<a name="34637057"></a>Paul A, Punati J. What is the evidence for over the counter laxatives to treat childhood constipation? <i>Curr Gastroenterol Rep</i>. 2021;23(11):19. doi:10.1007/s11894-021-00818-1<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/mineral-oil-pediatric-drug-information/abstract-text/34637057/pubmed" id="34637057" target="_blank">34637057</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-11466186">
<a name="11466186"></a>Sharif F, Crushell E, O'Driscoll K, Bourke B. Liquid paraffin: a reappraisal of its role in the treatment of constipation. <i>Arch Dis Child</i>. 2001;85(2):121-124. doi:10.1136/adc.85.2.121<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/mineral-oil-pediatric-drug-information/abstract-text/11466186/pubmed" id="11466186" target="_blank">11466186</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-8129503">
<a name="8129503"></a>Spickard A 3rd, Hirschmann JV. Exogenous lipoid pneumonia. <i>Arch Intern Med</i>. 1994;154(6):686-692.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/mineral-oil-pediatric-drug-information/abstract-text/8129503/pubmed" id="8129503" target="_blank">8129503</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-24345831">
<a name="24345831"></a>Tabbers MM, DiLorenzo C, Berger MY, et al. Evaluation and treatment of functional constipation in infants and children: evidence-based recommendations from ESPGHAN and NASPGHAN. <i>J Pediatr Gastroenterol Nutr</i>. 2014;58(2):258-274. doi:10.1097/MPG.0000000000000266<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/mineral-oil-pediatric-drug-information/abstract-text/24345831/pubmed" id="24345831" target="_blank">24345831</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-20084222">
<a name="20084222"></a>Weinstein M. First do no harm: The dangers of mineral oil. <i>Paediatr Child Health</i>. 2001;6(3):129-131. doi:10.1093/pch/6.3.129<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/mineral-oil-pediatric-drug-information/abstract-text/20084222/pubmed" id="20084222" target="_blank">20084222</a>]</span>
</div>
</li></ol></div><div id="topicVersionRevision">Topic 12614 Version 181.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
